Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Brain abnormalities in neuromyelitis optica spectrum disorder.
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Optimizing therapy early in multiple sclerosis: An evidence-based view.
Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.
Fingolimod and multiple sclerosis: Four cautionary tales.
Caregiver burden, quality of life and walking ability in different disability levels of multiple sclerosis.
Paroxetine-Related Adult-Onset Tic Disorder: A Presentation of Primary Progressive Multiple Sclerosis.
Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Ascl1/Mash1 Promotes Brain Oligodendrogenesis during Myelination and Remyelination.
Need for the upcoming revision of the current diagnostic criteria for NMO - response to the letter from Zhou et al.
Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
Impact of high intensity exercise on muscle morphology in EAE rats.
Characterization of anti-natalizumab antibodies in multiple sclerosis patients.
Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation.
Gait disorders in multiple sclerosis.
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
Local delivery of FTY720 in PCL membrane improves SCI functional recovery by reducing reactive astrogliosis.
Better look (and think) twice-TNF-alpha-inhibition and multiple sclerosis.

Pages